Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Continuous Glucose Monitor Use in Pregnancy

NCT: NCT05317585 · RECRUITING

NCT IDNCT05317585
StatusRECRUITING
Start Date2024-05-23
Completion2027-07-01
SponsorUniversity of Massachusetts, Worcester (OTHER)
First posted
Last updated

Brief Summary

The purpose of this study is to perform a randomized controlled trial among 180 pregnant women with type 2 diabetes mellitus (T2DM) comparing continuous glucose monitor (CGM) use to the standard of care of multiple daily fingerstick glucose monitoring and its impact on large for gestational age infants, maternal glycemic control, patient satisfaction, and additional adverse perinatal outcomes.

Frequently Asked Questions

What is Continuous Glucose Monitor Use in Pregnancy?

Continuous Glucose Monitor Use in Pregnancy is a clinical trial registered under NCT05317585. Current status: RECRUITING.

What is the status of NCT05317585?

The current status of NCT05317585 (Continuous Glucose Monitor Use in Pregnancy) is: RECRUITING.

When did Continuous Glucose Monitor Use in Pregnancy start?

Continuous Glucose Monitor Use in Pregnancy started on 2024-05-23.

Related Devices

K241335Eversense 365 Continuous Glucose Monitoring (CGM) SystemSenseonics, Incorporated PMA P160048Continuous glucose monitor, implanted, adjunctive useSenseonics, Incorporated

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑